Nanjing Leads Biolabs Co., Ltd. (HKG:9887)
Hong Kong
· Delayed Price · Currency is HKD 80.85
-0.85 (-1.04%)
Apr 29, 2026, 4:08 PM HKT
Nanjing Leads Biolabs Market Cap
Nanjing Leads Biolabs has a market cap or net worth of 15.97 billion as of April 29, 2026.
Market Cap
15.97B
Enterprise Value
14.56B
Revenue
197.25M
Ranking
n/a
PE Ratio
n/a
Stock Price
80.85
Market Cap Chart
Since July 25, 2025, Nanjing Leads Biolabs's market cap has increased from 12.97B to 15.97B, an increase of 23.11%. That is a compound annual growth rate of 31.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 15.97B | 57.47% |
| Dec 31, 2025 | 10.14B | -21.82% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ascentage Pharma Group International | 16.97B |
| CStone Pharmaceuticals | 15.76B |
| Ascletis Pharma | 19.00B |
| Zai Lab | 20.04B |
| CARsgen Therapeutics Holdings | 13.02B |
| Keymed Biosciences | 22.29B |
| Everest Medicines | 12.43B |
| TransThera Sciences (Nanjing) | 23.21B |